BACKGROUND: Cervical cancer screening efforts linked to HIV/AIDS care programs are being expanded across sub-Saharan Africa. Evidence on the age distribution and determinants of invasive cervical cancer (ICC) cases detected in such programs is limited. METHODS: We analyzed program operations data from the Cervical Cancer Prevention Program in Zambia, the largest public sector programs of its kind in sub-Saharan Africa. We examined age distribution patterns by HIV serostatus of histologically confirmed ICC cases and used multivariable logistic regression to evaluate independent risk factors for ICC among younger (≤35 years) and older (>35 years) women. RESULTS: Between January 2006 and April 2010, of 48,626 women undergoing screening, 571 (1.2%) were diagnosed with ICC, including 262 (46%) HIV seropositive (median age: 35 years), 131 (23%) HIV seronegative (median age: 40 years), and 178 (31%) of unknown HIV serostatus (median age: 38 years). Among younger (≤35 years) women, being HIV seropositive was associated with a 4-fold higher risk of ICC [adjusted odds ratio = 4.1 (95% confidence interval: 2.8, 5.9)] than being HIV seronegative. The risk of ICC increased with increasing age among HIV-seronegative women and women with unknown HIV serostatus, but among HIV-seropositive women, the risk peaked around age 35 and nonsignificantly declined with increasing ages. Other factors related to ICC included being married (vs. being unmarried/widowed) in both younger and older women, and with having 2+ (vs. ≤1) lifetime sexual partners among younger women. CONCLUSIONS: HIV infection seems to have increased the risk of cervical cancer among younger women in Zambia, pointing to the urgent need for expanding targeted screening interventions.
BACKGROUND:Cervical cancer screening efforts linked to HIV/AIDS care programs are being expanded across sub-Saharan Africa. Evidence on the age distribution and determinants of invasive cervical cancer (ICC) cases detected in such programs is limited. METHODS: We analyzed program operations data from the Cervical Cancer Prevention Program in Zambia, the largest public sector programs of its kind in sub-Saharan Africa. We examined age distribution patterns by HIV serostatus of histologically confirmed ICC cases and used multivariable logistic regression to evaluate independent risk factors for ICC among younger (≤35 years) and older (>35 years) women. RESULTS: Between January 2006 and April 2010, of 48,626 women undergoing screening, 571 (1.2%) were diagnosed with ICC, including 262 (46%) HIV seropositive (median age: 35 years), 131 (23%) HIV seronegative (median age: 40 years), and 178 (31%) of unknown HIV serostatus (median age: 38 years). Among younger (≤35 years) women, being HIV seropositive was associated with a 4-fold higher risk of ICC [adjusted odds ratio = 4.1 (95% confidence interval: 2.8, 5.9)] than being HIV seronegative. The risk of ICC increased with increasing age among HIV-seronegative women and women with unknown HIV serostatus, but among HIV-seropositivewomen, the risk peaked around age 35 and nonsignificantly declined with increasing ages. Other factors related to ICC included being married (vs. being unmarried/widowed) in both younger and older women, and with having 2+ (vs. ≤1) lifetime sexual partners among younger women. CONCLUSIONS:HIV infection seems to have increased the risk of cervical cancer among younger women in Zambia, pointing to the urgent need for expanding targeted screening interventions.
Authors: Groesbeck P Parham; Mulindi H Mwanahamuntu; Vikrant V Sahasrabuddhe; Andrew O Westfall; Kristin E King; Carla Chibwesha; Krista S Pfaendler; Gracilia Mkumba; Victor Mudenda; Sharon Kapambwe; Sten H Vermund; Michael L Hicks; Jeffrey Sa Stringer; Benjamin H Chi Journal: HIV Ther Date: 2010
Authors: Rebecca S Holmes; Stephen E Hawes; Papa Touré; Ahmadou Dem; Qinghua Feng; Noel S Weiss; Nancy B Kiviat Journal: Cancer Epidemiol Biomarkers Prev Date: 2009-08-18 Impact factor: 4.254
Authors: Jonah Musa; Chad J Achenbach; Charlesnika T Evans; Neil Jordan; Patrick H Daru; Lifang Hou; Robert L Murphy; Isaac F Adewole; Melissa A Simon Journal: BMC Health Serv Res Date: 2018-11-22 Impact factor: 2.655
Authors: Pierre-Marie Tebeu; Jean Pierre Ngou-Mve-Ngou; Laure Leka Zingué; Jesse Saint Saba Antaon; Etienne Okobalemba Atenguena; Julius Sama Dohbit Journal: Obstet Gynecol Int Date: 2021-10-13
Authors: Jonah Musa; Supriya D Mehta; Chad J Achenbach; Charlesnika T Evans; Neil Jordan; Francis A Magaji; Victor C Pam; Patrick H Daru; Olugbenga A Silas; Atiene S Sagay; Rose Anorlu; Yinan Zheng; Mamoudou Maiga; Isaac F Adewole; Robert L Murphy; Lifang Hou; Melissa A Simon Journal: Infect Agent Cancer Date: 2020-07-29 Impact factor: 2.965
Authors: Jonah Musa; Chad J Achenbach; Charlesnika T Evans; Neil Jordan; Patrick H Daru; Olugbenga Silas; Atiene S Sagay; Rose Anorlu; Supriya D Mehta; Firas Wehbe; Melissa A Simon; Isaac F Adewole; Lifang Hou; Robert L Murphy Journal: Infect Agent Cancer Date: 2019-11-29 Impact factor: 2.965